Cross-Linked Aβ Reference Material for Stable ASPD Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for stable, cost-effective reference materials to analyze amylospheroids (ASPD) for diagnostics and therapeutic agents targeting ASPD, as native and synthetic ASPD have issues with production, storage stability, and cost.
Innovation Solution
A cross-linked product of amyloid-β protein (Aβ) is developed using a cross-linking agent with a spacer arm length of 4 Å to 50 Å, which competes with ASPD-specific antibodies and can be used as a substitute or reference material for ASPD analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If native ASPD or synthetic ASPD are used as reference materials for ASPD analysis, then the analysis can be performed, but there are issues with production stability, storage stability, and production cost
Solution Approach 1:
The patent creates a cross-linked Aβ product that copies the essential structural and functional characteristics of native ASPD (spherical assembly of Aβ proteins) without requiring complex biological systems. By using chemical cross-linking agents on simpler Aβ aggregates, the invention produces a stable reference material that mimics ASPD's immunoreactivity while being easier and more stable to manufacture and store
Solution Approach 2:
The patent modifies the physical-chemical parameters of Aβ aggregates by introducing cross-links with specific cross-linking agents. This cross-linking stabilizes the aggregate structure, preventing dissociation during storage and handling, while maintaining the immunoreactive epitopes that ASPD-specific antibodies recognize. The cross-linked structure provides enhanced stability without requiring the complex production conditions of native ASPD
2Ease of manufacture
If synthetic ASPD are produced by slowly stirring liquid containing Aβ, then ASPD can be obtained, but the production process is time-consuming and storage stability is poor
Solution Approach 1:
The patent performs cross-linking during the aggregate formation process itself, rather than after. By adding cross-linking agents to the Aβ solution during aggregation, the structures are stabilized as they form, preventing later dissociation or degradation during storage. This preliminary stabilization action ensures storage stability without requiring additional post-processing steps
Solution Approach 2:
The patent creates a composite structure by combining Aβ proteins with cross-linking agents. This composite material has enhanced stability properties compared to pure Aβ aggregates, as the cross-links provide structural reinforcement that prevents dissociation during storage while maintaining the essential ASPD-like characteristics for antibody recognition
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cross-linked Aβ product exhibits reactivity similar to ASPD, enabling efficient analysis and detection in biospecimens, and can be used as a reference material for diagnostics and therapeutic agents targeting ASPD.
Implementation Method 1
A cross-linked product of amyloid-β protein (Aβ), that is, a cross-linked Aβ obtained through cross-linking with the use of a cross-linking agent
Data Source
Figure 1
Figure 2~3
Figure 4~5
AI summary
A substance that can be a substitute for amylospheroids (ASPD) and a method for analyzing ASPD are provided. Viewed from one aspect, the present disclosure relates to a substance in which amyloid-β protein (Aß) is cross-linked with a cross-linking agent that has a spacer arm length of between 4 Å and 50 Å inclusive or a cross-linking agent that has, as a spacer arm, not less than 1 and not more than 13 groups that are an oxyethylene group(s) (-CH2CH2O-) and/or an oxypropylene group(s) (-CH2CH2CH2O-).Viewed from another aspect, the present disclosure relates to a method for analyzing ASPD using the substance as a reference material.